HopeStage
Back to all studies
WithdrawnNCT01770600

Impulsivity and Thought Process Disorder in Patients With Active Suicide prevention and Depression

Medication studyAges 19–64United States
The study in practice

Understand this study

Who could participate?

This study is for people with depression. Listed age limits: 19 years to 64 years. Other eligibility criteria apply.

Listed locations
BirminghamSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateApril 2010
Recruitment status
Withdrawn
Enrollment listed in the registry
0
Sponsor
University of Alabama at Birmingham
Sponsor type
University
Study type
Drug
Intervention type
Drug, Other
Locations
United States
Age range
From 19 Years to 64 Years
Official registry ID
NCT01770600
Official title
Show the full official title

Assessment and Treatment of Impulsivity and Thought Process Disorder in Patients With Active Suicidal Ideation and Depression.

Recruitment & locations

Withdrawn

Birmingham

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Alabama at Birmingham, a university.

Does this study involve medication?

Yes. The study involves medication, including Riperidone.

Who can participate?

This study is for people with depression. Listed age limits: 19 years to 64 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as withdrawn.

Want to explore more studies?

Explore studies